CPR Invest - Biodiversity - A EUR - Acc ISIN : LU3110816249

CPR Invest - Biodiversity - A EUR - Acc
Asset class: Equities

YTD
As of 12/11/2026
15.72%

Risk IndicatorThe level of risk of the fund mainly reflects the risk of the market in which the fund is invested and, as the case may be, the leveraging strategy or inverse performance of the index. The capital initially invested does not benefit from any guarantee. The current level of risk does not indicate the future level of risk and may change over time. The lowest risk level is not equal to a risk-free investment.
1234567
Lower Risk
Higher Risk
The risk indicator assumes you keep the product according to the holding period.

NAV
As of 12/11/2026
€124.53

SFDR ClassificationSustainable Finance Disclosure Regulation
Art. 8

Fund AUM
As of 12/11/2026
€234.36M
The Compartment's objective is to outperform the MSCI World Index, over the recommended holding period (at least five years) through active management of international equities, while incorporating indicators for analysing the sustainability of biodiversity practices.

NAVs

NAV from 20/10/2025 to 12/11/2026
Select period
Created with Highcharts 11.4.8CPR Invest - Biodiversity - A EUR - AccNov '25Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26100105110115120125130

Performance

Change in NAV in base 100
FundCPR Invest - Biodiversity - A EUR - Acc (15.01% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Biodiversity - A EUR - AccBenchmark5 Jan2 Feb2 Mar30 Mar27 Apr25 May22 Jun20 Jul17 Aug14 Sep12 Oct9 Nov9095100105110115120
* Rolling performance : for funds that have been launched since less than 1 year or 3 years or 5 years, the performance showed in the table in the 1 year or 3 years or 5 years column is the performance since incentive of the fund.

All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.

Past performance does not guarantee future returns.The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.

The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).

The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.
FundCPR Invest - Biodiversity - A EUR - Acc (15.01% over the period)
Select period
Created with Highcharts 11.4.8CPR Invest - Biodiversity - A EUR - AccBenchmark5 Jan2 Feb2 Mar30 Mar27 Apr25 May22 Jun20 Jul17 Aug14 Sep12 Oct9 Nov9095100105110115120
* Rolling performance : for funds that have been launched since less than 1 year or 3 years or 5 years, the performance showed in the table in the 1 year or 3 years or 5 years column is the performance since incentive of the fund.

All performance figures are calculated in your selected currency based NAV to NAV with gross income accumulated.

Past performance does not guarantee future returns.The value of an investment can rise or fall with market fluctuations, and you may lose the amount originally invested. The material is based upon information that we consider reliable as of the date shown, but we do not represent that it is accurate, complete, valid or timely, in particular any data communicated to us by a third party, and it should not be relied on as such for any particular purpose. All material is subject to change.

The fund performance is calculated net of investment management fees including commissions and custody fees. The benchmark performances are calculated with net dividend reinvested when applicable. Both performances for funds and benchmarks are calculated using internal software fed by external sources (predominantly Datastream).

The exchange rates used to convert the benchmark and investment funds are the rates published by WM/Reuters at 16:00 (London time) on the last day of the month.

Portfolio Analysis

Repartition 10/31/2026
Created with Highcharts 11.4.8Values32.87​32.8717.41​17.4115.67​15.6711.31​11.317.60​7.605.37​5.372.89​2.892.71​2.711.50​1.501.18​1.1830.72​30.7210.75​10.7516.03​16.039.95​9.958.60​8.607.12​7.125.21​5.212.45​2.453.14​3.141.57​1.57PortfolioBenchmark024681012141618202224262830323436Information TechnologyIndustrialsFinancialsHealth CareConsumer DiscretionaryCommunication ServicesConsumer StaplesUtilitiesMaterialsReal EstateHighcharts.com

Management commentary

Effective date: 31/10/2026Key highlights of the month
October 2026 was marked by a strong rotation out of AI-related growth stocks and into more defensive, profitable assets that are less exposed to valuation risk. The Nasdaq-100 lost 6.7%, while the equal-weighted S&P 500 rose by about 5%, signaling a clear broadening of the market. Earnings releases from Alphabet, Microsoft, and Intel crystallized doubts about the sustainability of the AI capex boom: Alphabet saw a sharp correction after disappointing results in traditional search and a negative free cash flow, Microsoft raised its expected capex, and Intel suffered from disappointing guidance. At the same time, geopolitical tensions in the Middle East, the rebound and subsequent volatility in oil prices, and a more hawkish Fed than anticipated maintained a cautious climate, even though the 10-year Treasury yield eventually fell back to 4.9% at the end of the month.
The month clearly favored Value and Quality styles. The best-performing factors were those related to cash flow and valuation multiples, confirming investors’ renewed focus on companies capable of generating tangible cash. Conversely, growth and momentum factors suffered, reflecting the breakdown of outperformance among the most expensive and consensus AI stocks. Quality factors also held up well in an environment of heightened credit tensions.
Note:
On October 31, 2026, COP17 adopted a decisive agreement, the “Yerevan Pathway,” to accelerate measures conducive to achieving the 23 targets of the Global Biodiversity Framework (GBF) by 2030. The assessment is that states are lagging: of the 23 targets, only one is on track to be achieved by 2030. Four priority actions have emerged to focus on by 2030: 1) combating subsidies and incentives harmful to nature, 2) increasing financial, scientific, and technical support to developing countries, 3) aligning national budgets and economic decisions with the global biodiversity framework, and 4) strengthening implementation, monitoring, and reporting mechanisms.
 
Summary of the main positions of the month:
In October 2026, the fund posted an underperformance relative to its benchmark.
This relative underperformance is mainly explained by the absence of the energy sector, which saw a marked increase this month. US technology stocks also suffered, with the Nasdaq falling by 6%, which weighed on the growth stocks held in the portfolio. Despite these headwinds, the fund benefited from the strong performance of the healthcare and defensive sectors, which helped limit the gap with the benchmark.
The most significant performance drivers were strong earnings in healthcare, notably Biogen (+14%) and Gilead Sciences (+17%), as well as the rebound of defensive stocks such as Veolia and Badger Meter (+22%). Stock selection in software worked well with Autodesk (+21%), a position we are maintaining for its exposure to eco-design and natural risk simulation tools, particularly related to water and cities, as well as Synopsys (+9%). The absence of Meta Platforms (-14%) for ESG reasons benefited the fund.
Conversely, ServiceNow (-20%) and Xylem (-7%) suffered sharp corrections following broker downgrades and disappointing earnings releases, causing temporary volatility. In addition, environmental and biodiversity exclusions (Tesla +14%, Eli Lilly +24%) resulted in missed gains, consistent with the fund’s philosophy but at the expense of performance.
 
Outlook for the following month:
Portfolio management remained cautious, with reduced risk and few major moves. Veolia was increased after its decline, in line with a strong defensive and environmental rationale. Positions in ServiceNow and Xylem were maintained despite volatility, reflecting conviction in the potential of these stocks. Biodiversity exclusions continued, even though they cost performance this month. Finally, the fund is actively monitoring developments related to artificial intelligence, particularly the IPO of Anthropic, which could influence sector allocation in the medium term.
In conclusion, the fund remains positioned in growth and quality stocks, while maintaining prudent management in an unfavorable sector rotation environment. In a context marked by high interest rates, massive financing needs around AI, and persistent energy tensions, the priority remains the robustness of holdings and control of the benchmark gap. On the extra-financial front, the COP mainly confirmed the lag of states, while companies continue to make progress through TNFD reporting and engagement.

Characteristics

General data

Inception date
20/10/2025
First Nav Date
12/06/2025
Currency
EUR
Show more
Valuation
Daily
Minimum initial investment
1 10/1000° share(s)/equity
Minimum additional investment
1 10/1000° share(s)/equity

Costs Composition

One-off costs upon entry or exit (Investment EUR 10,000)If you exit after 1 year
Entry costsThis includes distribution costs of 5.00% of amount invested. This is the most you will be charged. The person selling you the product will inform you of the actual charge.Up to €500.00
Exit costsWe do not charge an exit fee for this product, but the person selling you the product may do so.€0.00
Ongoing costs taken each year (Investment EUR 10,000)
Management fees and other administrative or operating costs1.65% of the value of your investment per year. This percentage is based on actual costs over the last year.€156.75
Transaction costs0.20% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the underlying investments for the product. The actual amount will vary depending on how much we buy and sell.€19.00
Incidental costs taken under specific conditions (Investment EUR 10,000)
Performance fees

15.00% annual outperformance of the reference asset 100% MSCI WORLD NR Close. The calculation applies on each Net Asset Value calculation date in accordance with the terms described in the prospectus. Past underperformances over the last 5 years should be clawed back before any new accrual of performance fee.The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years.

The performance fee is paid even if the performance of the share over the performance observation period is negative, while remaining higher than the performance of the Reference Asset.

€0.00

Codification

ISIN code
LU3110816249
Bloomberg code
CPIBAEA LX
Reuters code
LP68884680

Investment Objective

The Compartment's objective is to outperform the MSCI World Index, over the recommended holding period (at least five years) through active management of international equities, while incorporating indicators for analysing the sustainability of biodiversity practices.

Documents

LanguageDocumentsTypeClosing Date
FI
PDF
01/09/2026
EN
PDF
31/07/2025
PDF
01/10/2026
PDF
31/01/2026
EN
PDF
26/10/2016
EN
PDF
31/12/2024
Prices expressed in a currency other than the base currency of the portfolio are available for information purposes only.
Nothing contained in this site constitutes a solicitation or offer by any member of the Amundi to provide any investment advice or service or to purchase or sell any financial instruments. The information it contains aims to inform the subscriber by providing information on the UCITS supplemental to that appearing in the Information Memorandum. The material provided on this site is presented as of the date shown and "as is". Amundi does not expressly or impliedly warrant the accuracy of the information provided on this site and expressly disclaims any warranties of fitness of this site for any particular purpose. This material reflects the opinion of the management company at the date of printing. The material is based upon information that we consider reliable, but we do not represent it is accurate, complete, valid or timely and it should not be relied on as such for any particular purpose. Any subscription should be based solely on the Information Memorandum provided to subscribers prior to the subscription and/or available upon request.

Institutional Sub-Class (Sub-Class I): Shares of this sub-class are only available to institutionals subscribing for their own account or within the framework of a collective savings or any comparable scheme, as well as UCITS. As such this Sub-Class benefits from the reduced "taxe d abonnement" of 0,01%. The minimum investment in this Sub-Class is USD 500,000.
Classic Sub-Class (Sub-Class C): Share of this sub-class are available to all investors. There is no minimum investment requirement in this sub-class.
Source : Amundi